Concepedia

Chris Doucette

CD

5

Publications

267

Citations

5

H-Index

2005

Active since

Affiliations

Athersys (United States)(Current)

Chris Doucette is an author at Athersys (United States) specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

2005–2010

5

Publications

5

Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment

Xi‐Ping Huang, Vincent Setola, Prem N. Yadav et al. · Molecular Pharmacology · 2009 · 137 citations · Full text

3-Indolyl sultams as selective CRTh2 antagonists

L. Nathan Tumey, Michael J. Robarge, Elizabeth Gleason et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 48 citations · Full text

, , +5

A Homogeneous Fluorescent Live-Cell Assay for Measuring 7-Transmembrane Receptor Activity and Agonist Functional Selectivity Through Beta-Arrestin Recruitment

Bonnie J. Hanson, Justin Wetter, Mark Bercher et al. · SLAS DISCOVERY · 2009 · 34 citations · Full text

Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists

Michael J. Robarge, David Bom, L. Nathan Tumey et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 24 citations · Full text

, , +6

Development of Homogeneous High-Affinity Agonist Binding Assays for 5-HT <sub>2</sub> Receptor Subtypes

Jianping Song, Douglas Hanniford, Chris Doucette et al. · Assay and Drug Development Technologies · 2005 · 24 citations

Rows per page

1–5 of 5